CD160 is essential for NK-mediated IFN-gamma production
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tu, Tony C. | - |
dc.contributor.author | Brown, Nicholas K. | - |
dc.contributor.author | Kim, Tae-Jin | - |
dc.contributor.author | Wroblewska, Joanna | - |
dc.contributor.author | Yang, Xuanming | - |
dc.contributor.author | Guo, Xiaohuan | - |
dc.contributor.author | Lee, Seoyun Hyunji | - |
dc.contributor.author | Kumar, Vinay | - |
dc.contributor.author | Lee, Kyung-Mi | - |
dc.contributor.author | Fu, Yang-Xin | - |
dc.date.accessioned | 2021-09-04T18:32:50Z | - |
dc.date.available | 2021-09-04T18:32:50Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2015-03 | - |
dc.identifier.issn | 0022-1007 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/94207 | - |
dc.description.abstract | NK-derived cytokines play important roles for natural killer (NK) function, but how the cytokines are regulated is poorly understood. CD160 is expressed on activated NK or T cells in humans but its function is unknown. We generated CD160-deficient mice to probe its function. Although CD160(-/-) mice showed no abnormalities in lymphocyte development, the control of NK-sensitive tumors was severely compromised in CD160(-/-) mice. Surprisingly, the cytotoxicity of NK cells was not impaired, but interferon-gamma (IFN-gamma) secretion by NK cells was markedly reduced in CD160(-/-) mice. Functionally targeting CD160 signaling with a soluble CD160-Ig also impaired tumor control and IFN-gamma production, suggesting an active role of CD160 signaling. Using reciprocal bone marrow transfer and cell culture, we have identified the intrinsic role of CD160 on NK cells, as well as its receptor on non-NK cells, for regulating cytokine production. To demonstrate sufficiency of the CD160(+) NK cell subset in controlling NK-dependent tumor growth, intratumoral transfer of the CD160(+) NK fraction led to tumor regression in CD160(-/-) tumor-bearing mice, indicating demonstrable therapeutic potential for controlling early tumors. Therefore, CD160 is not only an important biomarker but also functionally controls cytokine production by NK cells. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ROCKEFELLER UNIV PRESS | - |
dc.subject | HERPESVIRUS ENTRY MEDIATOR | - |
dc.subject | T-LYMPHOCYTE ATTENUATOR | - |
dc.subject | NATURAL-KILLER-CELLS | - |
dc.subject | MHC CLASS-I | - |
dc.subject | CUTTING EDGE | - |
dc.subject | B-LYMPHOCYTE | - |
dc.subject | ACTIVATING RECEPTORS | - |
dc.subject | SIGNALING PATHWAYS | - |
dc.subject | HLA-C | - |
dc.subject | ENGAGEMENT | - |
dc.title | CD160 is essential for NK-mediated IFN-gamma production | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kyung-Mi | - |
dc.identifier.doi | 10.1084/jem.20131601 | - |
dc.identifier.scopusid | 2-s2.0-84924655166 | - |
dc.identifier.wosid | 000350873300012 | - |
dc.identifier.bibliographicCitation | JOURNAL OF EXPERIMENTAL MEDICINE, v.212, no.3, pp.415 - 429 | - |
dc.relation.isPartOf | JOURNAL OF EXPERIMENTAL MEDICINE | - |
dc.citation.title | JOURNAL OF EXPERIMENTAL MEDICINE | - |
dc.citation.volume | 212 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 415 | - |
dc.citation.endPage | 429 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | HERPESVIRUS ENTRY MEDIATOR | - |
dc.subject.keywordPlus | T-LYMPHOCYTE ATTENUATOR | - |
dc.subject.keywordPlus | NATURAL-KILLER-CELLS | - |
dc.subject.keywordPlus | MHC CLASS-I | - |
dc.subject.keywordPlus | CUTTING EDGE | - |
dc.subject.keywordPlus | B-LYMPHOCYTE | - |
dc.subject.keywordPlus | ACTIVATING RECEPTORS | - |
dc.subject.keywordPlus | SIGNALING PATHWAYS | - |
dc.subject.keywordPlus | HLA-C | - |
dc.subject.keywordPlus | ENGAGEMENT | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.